health

UCLA Jonsson Comprehensive Cancer Center researchers discuss the parallels — and the sometimes unexpected intersections between the two pursuits.

Blood donors representing many ethnicities and backgrounds pool precious resource to save woman’s life.

The device, developed by UCLA’s Aydogan Ozcan and colleagues in Sweden, could be manufactured for less than $500 each — far less expensive than the equipment that labs use for the same tests.

Dr. Edward Garon, UCLA Jonsson Comprehensive Cancer Center member and associate professor of hematology and oncology at the David Geffen School of Medicine, has received a new grant from the National Institutes of Health.

To turn on its genome — the full set of genes inherited from each parent — a mammalian embryo needs to relocate a group of proteins, researchers have discovered. The metabolic proteins move to the DNA-containing nuclei about two days after a mouse embryo is fertilized, according to the study.

California State Senate will discuss barriers, such as difficult-to-navigate health system, inadequate insurance, and cultural misconceptions, as well as possible solutions Jan. 12.

UCLA and the Los Angeles LGBT Center have developed a risk calculator that could help men who have sex with men decide whether to take pre-exposure prophylaxis.

Researchers believe that modulating electrical signals in the autonomic nervous system holds promise for better ways to treat heart failure and other common cardiovascular problems.

UCLA-led research found people with advanced head and neck squamous cell carcinoma and a certain genetic mutation have improved survival when given a drug in combination with standard therapies.

Jonathan Fielding writes that universal adoption of flouridated water and bolstering the number of dentists accepting Medicaid could help counter the inequality.

Amidst uncertain changes to federal health care policy, Gerald Kominski explores the future for California’s successful health care exchange and Medi-Cal programs.

The discovery could have important implications for treating white matter strokes, a major cause of dementia that also accelerate Alzheimer’s disease.

There are ways to both enjoy the holidays and keep healthy at the same time, says Erin Morse, chief clinical dietitian at the Ronald Reagan UCLA Medical Center.

The team found a way to correct the instability by resetting the stem cells from a later stage of development to an earlier stage. These results could have great impact on the creation of healthy tissues to cure disease.

Nearly half of 125 pregnancies studied resulted in defects among newborns or ended in fetal death.

A simple and inexpensive attachment could help to expand testing to regions with limited resources.

The findings could help improve upon standard behavioral therapy, in which people are exposed to the objects they’re afraid of — which can be frightening enough that some cannot complete treatment.

The California Health Interview Survey data show the rate of uninsured Californians fell to a new low in 2015, and fewer Californians cited cost as a reason to skip needed medical care.

The approach being tested at UCLA is designed to boost patients’ abilities to move their own hands; it’s unique because the device is implanted in the spine instead of the brain.

Researchers from the schools of dentistry, medicine and engineering developed a digital health platform capable of optimizing efficacy and safety during chemotherapy.

Neuroscientists at UCLA have developed a new technique for studying a particular type of cell in the brain known as an astrocyte that may play a role in diseases such as Lou Gehrig’s disease and Alzheimer's disease.

Experts from the UCLA School of Dentistry and Fielding School of Public Health make recommendations based on UCLA-First 5 LA program achievements.

UCLA researchers have discovered a previously unrecognized type of progenitor cell that is found in uncommonly high numbers in inflamed areas of the gland.

UCLA’s Dr. Daniel Geschwind said the findings could point the way to the development of drugs that reverse the specific type of gene activity patterns in the brains of people with the disorder.

The findings could one day lead to improved therapies for people undergoing chemotherapy and radiation treatment for cancer.